RevitaCare Dynamics
About
An early-stage investor focused on precision diagnostics, clinical intelligence, and interventional medical technologies
Investment Approach
RevitaCare Dynamics invests in medical technology companies that improve how clinical decisions are made, informed, and executed.
We focus on technologies that generate actionable clinical insight, enhance decision-making, and enable more effective intervention across the care continuum.
• Precision Diagnostics: Technologies that generate clinically actionable insights for earlier and more accurate disease detection.
• Clinical Intelligence: Software platforms that enhance clinical decision-making and workflow efficiency.
• Interventional Technologies: Devices and enabling technologies that improve the precision, safety, and effectiveness of medical procedures.
Portfolio
Precision Oncology
Improves accuracy of treatment selection for cancer patients
Medical Robotics
Precise, intuitive control over robotic operations and automated systems
Cardiovascular Interventional Devices
Minimally invasive therapies for heart failure patients
Cardiovascular Diagnostics
Faster, lower-cost triage of coronary artery disease in Emergency Departments
Medical Robotics
AI-powered robotic systems for minimally invasive surgery
Genetic Population Health
Enables Caribbean population genomics and precision medicine
Founder
Marlon Thompson, Ph.D., is a seasoned healthcare executive with a passion for driving innovation in medical diagnostics and improving patient care. With over two decades of experience in leading global businesses and driving innovation in medical diagnostics and life sciences, he has held leadership positions at prominent companies including Abbott Laboratories, Royal Philips, Leica Biosystems, and Siemens Healthcare Diagnostics.
Dr. Thompson's career highlights include leading the commercial launch of the first FDA-approved blood test for mild traumatic brain injury, leading the development of the global clinical Digital Pathology market, and driving strategic acquisitions to expand business portfolios. He has also advised some of the largest global healthcare companies as a McKinsey management consultant. His expertise spans commercial operations, product development, and business strategy, with a particular focus on advancing healthcare through new technology introduction.
A scientist by training, he holds a Ph.D. in Chemistry and has authored multiple patent and peer-reviewed publications. He combines his scientific background with strong business acumen, having earned an MBA from The Wharton School at the University of Pennsylvania. His blend of scientific knowledge and business leadership gives him a unique ability to assess healthcare technologies and support the growth of the companies that develop them.
Contact Us